Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors

BACKGROUND: We evaluated the mutation status of c-Met in small cell lung cancer (SCLC) and neuroendocrine tumors (NET), for which relatively limited therapeutic targets have been explored. MATERIALS AND METHODS: c-Met was re-sequenced using cell lines and clinical samples. For in vitro studies, DNA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Pharm Des
Autors principals: Voortman, J., Harada, T., Chang, R.P., Killian, J.K., Suuriniemi, M., Smith, W.I., Meltzer, P.S., Lucchi, M., Wang, Y., Giaccone, G.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569720/
https://ncbi.nlm.nih.gov/pubmed/22973954
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars